Contributors |
|
xiii | |
Foreword |
|
xxxiii | |
Preface |
|
xxxv | |
|
SECTION 1 Foundation Issues |
|
|
1 | (20) |
|
|
|
|
1 The Patient Care Process |
|
|
1 | (8) |
|
|
|
|
e2 Health Literacy and Medication Use |
|
|
9 | (2) |
|
|
|
|
|
|
11 | (2) |
|
|
|
|
Jessica M. Shenberger-Trujillo |
|
|
e4 Medication Safety Principles and Practices |
|
|
13 | (2) |
|
|
e5 Clinical Pharmacokinetics and Pharmacodynamics |
|
|
15 | (2) |
|
|
|
17 | (2) |
|
|
|
|
19 | (2) |
|
|
|
SECTION 2 Common Health Problems |
|
|
21 | (40) |
|
|
|
|
|
21 | (2) |
|
|
|
|
23 | (2) |
|
|
|
|
e10 Minor Ophthalmic Disorders |
|
|
25 | (2) |
|
|
|
27 | (2) |
|
|
e12 Cough and Other Nonspecific Respiratory Symptoms |
|
|
29 | (2) |
|
|
|
31 | (2) |
|
|
e14 Oral Health and Systemic Conditions |
|
|
33 | (2) |
|
|
|
e15 Oral Hygiene and Minor Oral Disorders |
|
|
35 | (2) |
|
|
|
|
e16 Skin Care and Minor Dermatologic Conditions |
|
|
37 | (2) |
|
|
|
|
39 | (2) |
|
|
|
|
41 | (20) |
|
Shareen Y. El-lbiary Sarah P. Shrader |
|
|
|
SECTION 3 Special Populations |
|
|
61 | (20) |
|
|
|
e19 Pediatrics: General Topics in Pediatric Pharmacotherapy |
|
|
61 | (2) |
|
|
|
e20 Pediatrics: Oral Nutrition and Rehydration of Infants and Children |
|
|
63 | (2) |
|
|
e21 Pediatrics: Neonatal Critical Care |
|
|
65 | (2) |
|
|
|
e22 Geriatrics: The Aging Process in Humans and Its Effects on Physiology |
|
|
67 | (2) |
|
|
|
|
|
e23 Prescribing in the Older Adult |
|
|
69 | (2) |
|
|
|
|
e24 Assessing Health and Delivering Healthcare to Older Adults |
|
|
71 | (2) |
|
|
|
|
e25 Critical Care: General Topics in Critical Care |
|
|
73 | (2) |
|
|
|
e26 Critical Care: Pain, Agitation, and Delirium |
|
|
75 | (2) |
|
|
|
e27 Critical Care: Considerations in Drug Selection, Dosing, Monitoring, and Safety |
|
|
77 | (2) |
|
|
|
|
79 | (2) |
|
|
|
SECTION 4 Cardivascular Disorders |
|
|
81 | (288) |
|
|
e29 Assessment of the Cardiovascular System |
|
|
81 | (2) |
|
|
|
|
|
83 | (34) |
|
|
|
|
117 | (20) |
|
|
|
32 Stable Ischemic Heart Disease |
|
|
137 | (24) |
|
|
|
|
33 Acute Coronary Syndrome |
|
|
161 | (28) |
|
|
|
|
e34 Peripheral Arterial Disease |
|
|
189 | (2) |
|
|
|
|
191 | (30) |
|
|
|
|
36 Acute Decompensated Heart Failure |
|
|
221 | (20) |
|
|
|
37 Venous Thromboembolism |
|
|
241 | (32) |
|
|
|
|
|
273 | (14) |
|
|
|
|
287 | (38) |
|
|
|
|
|
325 | (18) |
|
|
|
343 | (26) |
|
|
|
|
SECTION 5 Respiratory Disorders |
|
|
369 | (92) |
|
|
e42 Evaluation of Respiratory Function |
|
|
369 | (2) |
|
|
|
|
|
|
371 | (34) |
|
|
|
44 Chronic Obstructive Pulmonary Disease |
|
|
405 | (26) |
|
|
|
45 Pulmonary Arterial Hypertension |
|
|
431 | (18) |
|
|
|
|
|
449 | (10) |
|
|
|
e47 Drug-Induced Pulmonary Diseases |
|
|
459 | (2) |
|
|
|
SECTION 6 Gastrointestinal Disorders |
|
|
461 | (162) |
|
|
e48 Evaluation of the Gastrointestinal Tract |
|
|
461 | (2) |
|
|
|
49 Gastroesophageal Reflux Disease |
|
|
463 | (20) |
|
|
|
|
50 Peptic Ulcer Disease and Related Disorders |
|
|
483 | (24) |
|
|
|
51 Inflammatory Bowel Disease |
|
|
507 | (22) |
|
|
|
529 | (14) |
|
Leigh Anne Hylton Gravatt |
|
|
|
|
53 Diarrhea, Constipation, and Irritable Bowel Syndrome |
|
|
543 | (18) |
|
|
|
54 Portal Hypertension and Cirrhosis |
|
|
561 | (16) |
|
|
|
e55 Drug-Induced Liver Disease |
|
|
577 | (2) |
|
|
|
|
579 | (16) |
|
|
|
|
595 | (20) |
|
|
|
615 | (8) |
|
|
|
SECTION 7 Renal Disorders |
|
|
623 | (210) |
|
|
e59 Evaluation of Kidney Function |
|
|
623 | (2) |
|
|
|
625 | (22) |
|
|
|
|
61 Chronic Kidney Disease |
|
|
647 | (30) |
|
|
|
|
62 Hemodialysis and Peritoneal Dialysis |
|
|
677 | (20) |
|
|
|
|
63 Drug-Induced Kidney Disease |
|
|
697 | (18) |
|
|
|
|
715 | (24) |
|
|
|
65 Drug Therapy Individualization for Patients with Chronic Kidney Disease |
|
|
739 | (16) |
|
|
|
66 Disorders of Sodium and Water Homeostasis |
|
|
755 | (24) |
|
|
|
67 Disorders of Calcium and Phosphorus Homeostasis |
|
|
779 | (18) |
|
|
|
68 Disorders of Potassium and Magnesium Homeostasis |
|
|
797 | (16) |
|
|
|
813 | (20) |
|
|
|
SECTION 8 Neurologic Disorders |
|
|
833 | (174) |
|
|
e70 Evaluation of Neurologic Illness |
|
|
833 | (2) |
|
|
|
|
835 | (18) |
|
|
|
|
|
|
|
853 | (24) |
|
|
|
|
|
|
877 | (36) |
|
|
|
|
|
913 | (16) |
|
|
|
75 Acute Management of the Brain Injury Patient |
|
|
929 | (16) |
|
|
|
|
945 | (14) |
|
|
|
|
959 | (30) |
|
|
|
|
|
989 | (18) |
|
|
|
SECTION 9 Psychiatric Disorders |
|
|
1007 | (222) |
|
|
e79 Evaluation of Psychiatric Disorders |
|
|
1007 | (2) |
|
|
|
|
|
80 Attention Deficit/Hyperactivity Disorder |
|
|
1009 | (20) |
|
|
|
|
|
1029 | (14) |
|
|
|
|
82 Substance Use Disorders I: Depressants, Stimulants, and Hallucinogens |
|
|
1043 | (26) |
|
|
|
|
83 Substance-Related Disorders II: Alcohol, Nicotine, and Caffeine |
|
|
1069 | (22) |
|
|
|
|
|
1091 | (34) |
|
|
|
|
85 Major Depressive Disorder |
|
|
1125 | (24) |
|
|
|
1149 | (16) |
|
|
|
87 Anxiety Disorders: Generalized Anxiety, Panic, and Social Anxiety Disorders |
|
|
1165 | (22) |
|
|
|
88 Posttraumatic Stress Disorder and Obsessive-Compulsive Disorder |
|
|
1187 | (14) |
|
|
|
|
|
1201 | (14) |
|
|
|
90 Intellectual and Developmental Disabilities: Down Syndrome and Autism Spectrum Disorder |
|
|
1215 | (14) |
|
|
SECTION 10 Endocrinologic Disorders |
|
|
1229 | (1) |
|
|
|
1229 | (36) |
|
|
|
|
1265 | (26) |
|
|
|
93 Adrenal Gland Disorders |
|
|
1291 | (22) |
|
|
|
|
e94 Pituitary Gland Disorders |
|
|
1313 | (2) |
|
|
|
|
SECTION 11 Gynecologic and Obstetric Disorders |
|
|
1315 | (1) |
|
|
95 Pregnancy and Lactation: Therapeutic Considerations |
|
|
1315 | (20) |
|
|
|
96 Menstruation-Related Disorders |
|
|
1335 | (18) |
|
|
|
|
1353 | (10) |
|
|
|
98 Hormone Therapy in Women |
|
|
1363 | (20) |
|
|
|
|
SECTION 12 Urologic Disorders |
|
|
1383 | (68) |
|
|
|
1383 | (28) |
|
|
|
100 Benign Prostatic Hyperplasia |
|
|
1411 | (20) |
|
|
|
|
1431 | (20) |
|
|
|
|
SECTION 13 Immunologic Disorders |
|
|
1451 | (46) |
|
|
|
e102 Function and Evaluation of the Immune System |
|
|
1451 | (2) |
|
|
|
103 Systemic Lupus Erythematosus |
|
|
1453 | (18) |
|
|
|
1471 | (2) |
|
|
|
105 Solid-Organ Transplantation |
|
|
1473 | (24) |
|
|
|
SECTION 14 Rheumatologic Disorders |
|
|
1497 | (92) |
|
|
|
|
1497 | (20) |
|
|
|
|
1517 | (20) |
|
|
|
|
|
1537 | (30) |
|
|
|
|
|
109 Gout and Hyperuricemia |
|
|
1567 | (22) |
|
|
|
SECTION 15 Ophthalmic Disorders |
|
|
1589 | (34) |
|
|
|
1589 | (18) |
|
|
|
|
|
111 Age-Related Macular Degeneration |
|
|
1607 | (14) |
|
|
|
e112 Drug-Induced Ophthalmic Disorders |
|
|
1621 | (2) |
|
|
SECTION 16 Dermatologic Disorders |
|
|
1623 | (86) |
|
|
|
1623 | (30) |
|
|
|
1653 | (22) |
|
|
|
|
1675 | (16) |
|
|
|
|
|
1691 | (16) |
|
|
|
|
e117 Dermatologic Drug Reactions, Contact Dermatitis, and Common Skin Conditions |
|
|
1707 | (2) |
|
|
|
|
SECTION 17 Hematologic Disorders |
|
|
1709 | (60) |
|
|
|
1709 | (20) |
|
|
|
119 Coagulation Disorders |
|
|
1729 | (18) |
|
|
|
|
|
1747 | (20) |
|
|
|
e121 Drug-Induced Hematologic Disorders |
|
|
1767 | (2) |
|
|
|
SECTION 18 Infectious Diseases |
|
|
1769 | (398) |
|
|
e122 Laboratory Tests to Direct Antimicrobial Pharmacotherapy |
|
|
1769 | (2) |
|
|
|
|
|
123 Antimicrobial Regimen Selection |
|
|
1771 | (14) |
|
|
|
124 Central Nervous System Infections |
|
|
1785 | (18) |
|
|
|
|
|
|
125 Lower Respiratory Tract Infections |
|
|
1803 | (24) |
|
|
|
126 Upper Respiratory Tract Infections |
|
|
1827 | (12) |
|
|
|
|
1839 | (16) |
|
|
128 Skin and Soft-Tissue Infections |
|
|
1855 | (28) |
|
|
129 Infective Endocarditis |
|
|
1883 | (18) |
|
|
|
|
1901 | (22) |
|
|
|
131 Gastrointestinal Infections and Enterotoxigenic Poisonings |
|
|
1923 | (16) |
|
|
|
132 Intra-Abdominal Infections |
|
|
1939 | (16) |
|
|
|
|
1955 | (2) |
|
|
134 Urinary Tract Infections and Prostatitis |
|
|
1957 | (18) |
|
|
|
135 Sexually Transmitted Infections |
|
|
1975 | (20) |
|
|
|
136 Bone and Joint Infections |
|
|
1995 | (12) |
|
|
|
137 Sepsis and Septic Shock |
|
|
2007 | (18) |
|
|
|
138 Superficial Fungal Infections |
|
|
2025 | (20) |
|
|
|
139 Invasive Fungal Infections |
|
|
2045 | (34) |
|
|
140 Infections in Immunocompromised Patients |
|
|
2079 | (32) |
|
|
|
141 Antimicrobial Prophylaxis in Surgery |
|
|
2111 | (16) |
|
|
142 Vaccines and Immunoglobulins |
|
|
2127 | (16) |
|
|
143 Human Immunodeficiency Virus Infection |
|
|
2143 | (24) |
|
|
|
|
SECTION 19 Oncologic Disorders |
|
|
2167 | (300) |
|
|
144 Cancer Treatment and Chemotherapy |
|
|
2167 | (54) |
|
|
|
|
2221 | (34) |
|
|
|
|
|
2255 | (18) |
|
|
|
|
2273 | (28) |
|
|
|
|
|
2301 | (18) |
|
|
|
2319 | (28) |
|
|
|
|
|
2347 | (18) |
|
|
|
|
2365 | (22) |
|
|
|
|
2387 | (22) |
|
|
|
|
2409 | (16) |
|
|
|
e154 Myelodysplastic Syndromes |
|
|
2425 | (2) |
|
|
e155 Renal Cell Carcinoma |
|
|
2427 | (2) |
|
|
|
|
2429 | (20) |
|
|
|
|
157 Hematopoietic Stem Cell Transplantation |
|
|
2449 | (18) |
|
|
|
SECTION 20 Nutritional Disorders |
|
|
2467 | (88) |
|
|
158 Assessment of Nutrition Status and Nutrition Requirements |
|
|
2467 | (24) |
|
|
|
|
2491 | (22) |
|
|
|
|
2513 | (18) |
|
|
|
|
2531 | (24) |
|
|
|
Index |
|
2555 | |